The Saudi Arabia infection control market is estimated to grow at a CAGR of 9.53% over the forecast period. With the increasing prevalence of chronic diseases along with the highest rate of road accidents in the world, Saudi Arabia infection control market is projected to grow with a significant growth rate in the forecast period. With the evolving healthcare landscape of the country, the market is estimated to continue to grow in the forecast period. The growing health privatization with intent to reducing dependence on the public sector is providing an opportunity for the market to increase at a rapid pace over the next five years.
The significant contribution of the healthcare sector to the national GDP is proving to contribute to the growth of the healthcare industry, further creating strong market growth prospects during the forecast period. The growing number of hospital beds in all the hospitals in the country is further projected to surge the market growth in the forecast period and in the upcoming years. The growth of the pharmaceutical industry in the Kingdom of Saudi Arabia with the growing domestic manufacturing base is estimated to augment the market growth in the upcoming years.
The growing healthcare privatization is driving the market demand in the forecast period and in the upcoming years.
At present, public spending is still dominating in the country. However, significant efforts are being made in the expansion of privatization of government services in the healthcare sector as well, propagating the market demand in the forecast period and in the upcoming years. The evolving healthcare of Saudi Arabia, with the evolving lifestyle of the citizens, the government of KSA is boosting privatization in the country as this will result in the reduction of dependency on the public sector. The privatization of all the public hospitals in the country is projected to fulfill the objectives of the government’s National Transformation Program (NTP) 2020. The objectives include the expansion of the role of the private sector, increasing the number of licensed medical facilities, and double the number of primary care centers per capita visits from two to four among other objectives. Such initiatives will further surge the market growth in the forecast period and in the upcoming years.
The growing pharmaceutical sector with encouraging domestic manufacturing of pharma products is providing an opportunity for the market to grow in the upcoming years.
Significant initiatives for the domestic manufacturing of pharmaceutical products is poised to augment the market demand in the upcoming years. Also, as per the government plan, the local manufacturing base of the pharmaceuticals will also promote technology transfer, conducting clinical trials in Saudi Arabia, and training of the Saudi labour force. The 2030 Vision, and National transformation program are set to develop five industrial sectors which include the pharma and biotech industry as well. The following opportunities are identified for the growth of the pharma industry in the KSA, this includes biologics and biosimilars, vaccine formulation, sterile injectables, solid oral dosage, and API among others.
Segmentation:
By Product
By End User Industry
The significant contribution of the healthcare sector to the national GDP is proving to contribute to the growth of the healthcare industry, further creating strong market growth prospects during the forecast period. The growing number of hospital beds in all the hospitals in the country is further projected to surge the market growth in the forecast period and in the upcoming years. The growth of the pharmaceutical industry in the Kingdom of Saudi Arabia with the growing domestic manufacturing base is estimated to augment the market growth in the upcoming years.
The growing healthcare privatization is driving the market demand in the forecast period and in the upcoming years.
At present, public spending is still dominating in the country. However, significant efforts are being made in the expansion of privatization of government services in the healthcare sector as well, propagating the market demand in the forecast period and in the upcoming years. The evolving healthcare of Saudi Arabia, with the evolving lifestyle of the citizens, the government of KSA is boosting privatization in the country as this will result in the reduction of dependency on the public sector. The privatization of all the public hospitals in the country is projected to fulfill the objectives of the government’s National Transformation Program (NTP) 2020. The objectives include the expansion of the role of the private sector, increasing the number of licensed medical facilities, and double the number of primary care centers per capita visits from two to four among other objectives. Such initiatives will further surge the market growth in the forecast period and in the upcoming years.
The growing pharmaceutical sector with encouraging domestic manufacturing of pharma products is providing an opportunity for the market to grow in the upcoming years.
Significant initiatives for the domestic manufacturing of pharmaceutical products is poised to augment the market demand in the upcoming years. Also, as per the government plan, the local manufacturing base of the pharmaceuticals will also promote technology transfer, conducting clinical trials in Saudi Arabia, and training of the Saudi labour force. The 2030 Vision, and National transformation program are set to develop five industrial sectors which include the pharma and biotech industry as well. The following opportunities are identified for the growth of the pharma industry in the KSA, this includes biologics and biosimilars, vaccine formulation, sterile injectables, solid oral dosage, and API among others.
Segmentation:
By Product
- Disinfectant
- Sterilization
- Low temperature Sterilization
- Heat Sterilization
- Contract Sterilization
By End User Industry
- Healthcare
- Food and Beverage
- Chemical
Table of Contents
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
5. Saudi Arabia Infection Control Market Analysis, by Product
6. Saudi Arabia Infection Control Market Analysis, by End User Industry
7. Competitive Environment and Analysis
8. Company Profiles
Companies Mentioned
- 3M
- Franke Medical Oy
- Cantel Medical
- AlKifah Infection Control Solutions
Methodology
LOADING...
